Health & Wellness

Press Releases

Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer

a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg
a07d2d57403ac43db2c4_Dr._Angela_Alistar_2017.jpg

Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical trial of CPI-613 in combination with chemotherapeutic agents, gemcitabine and nab-paclitaxel, for patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in collaboration with Atlantic Health System. CPI-613 is a first-in-class drug with a unique mode of action and is Rafael’s lead altered energy metabolism directed (AEMD) drug candidate. The drug is designed to disrupt the altered energy-production pathways in cancer cells by targeting their mitochondrial metabolism.

The primary aim of the study is to establish the maximum tolerated dose of CPI-613 when given in combination with gemcitabine/nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer.

Secondary aims include:

Sign Up for E-News

(1) To describe the safety profile for the gemcitabine/nab-paclitaxel/CPI-613 combination.
(2) To determine the clinical activity of gemcitabine/nab-paclitaxel/CPI-613 in metastatic pancreatic cancer as measured by tumor response rate (RR) by RECIST criteria, progression-free survival (PFS), and overall survival (OS).

Encouraging results observed in earlier trials, including Phase I data from a trial led by Angela Alistar, MD that was recently published in The Lancet Oncology, demonstrated the preliminary efficacy of CPI-613 in combination with modified FOLFIRINOX (a multidrug treatment for advanced pancreatic cancer) in patients with metastatic pancreatic cancer. These results support further evaluation of CPI-613 in this indication.[1] The safety profile of CPI-613 in earlier trials, which shows the drug to be well tolerated, provides further support for evaluation of CPI-613 in combination with other drugs to maximize benefit.

In 2013, the MPACT study, a multinational, phase III clinical trial comparing gemcitabine/nab-paclitaxel to gemcitabine alone, demonstrated an improved median survival of 8.5 months as compared with 6.7 months for gemcitabine monotherapy (p=0.000015). While some clinical benefit was shown, these outcomes also highlight the need for new combination strategies to improve upon the outcomes seen with gemcitabine/nab-paclitaxel in the treatment of metastatic pancreatic cancer.

Dr. Alistar, medical director of GI Medical Oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System, and the Principal Investigator for this trial, remarked, “Strategies to enhance our current standard of care options are sorely needed in pancreatic cancer. Due to the low toxicity profile of CPI -613 as a single agent, I anticipate good tolerance in combination with the gemcitabine/nab-paclitaxel regimen. I am excited to be able to offer this novel option to our patients with pancreatic cancer. Targeting metabolism in pancreatic cancer has a strong scientific rationale.”

Sanjeev Luther, Rafael Pharmaceuticals’ Chief Executive Officer, commented, “Our company’s motto of “One Patient at a Time” is especially relevant in this situation. Patients with a low tolerance for toxicity may not be eligible for the FOLFIRINOX combo. We believe that the gemcitabine/nab-paclitaxel regimen has the potential to be a potent treatment with less toxicity. It is especially meaningful for us to announce the initiation of this study on World Pancreatic Cancer Day.”

About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of 16,000 team members dedicated to building healthier communities. The system is comprised of 350 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital. Atlantic Health System also supports communities through Atlantic Medical Group, Atlantic Rehabilitation, Atlantic Home Care and Hospice, and its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System sponsors the Atlantic Accountable Care Organization, one of the larger ACOs in the nation, and Optimus Healthcare Partners. 

 

About Rafael Pharmaceuticals, Inc.

Rafael Pharmaceuticals, Inc. is a clinical-stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael’s primary objective is to develop highly selective and effective agents with minimal toxic effects on normal cells and tissues. Rafael’s first-in-class clinical lead compound, CPI-613 is being evaluated in multiple Phase I, I/II, and II clinical studies. The U.S. Food and Drug Administration (FDA) has given Rafael approval to initiate pivotal clinical trials in pancreatic cancer and acute myeloid leukemia (AML), and has designated CPI-613 an orphan drug for the treatment of pancreatic cancer, AML, and myelodysplastic syndromes (MDS). The company's investors include IDT Corporation (NYSE: IDT). For more information, visit http://www.rafaelpharma.com/.

 

Safe Harbor Statement

This press release contains forward-looking statements. These statements relate to future events or the company’s future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "predict", "potential" or "continue", the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the company, or any other person, that such forward-looking statements will be achieved. The business and operations of the company are subject to substantial risks which increase the uncertainty inherent in forward-looking statements. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.

Reference

[1] Alistar A, Morris BB, Desnoyer R, et al. (2017). Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. The Lancet Oncology. doi: 10.1016/S1470-2045(17)30314-5.

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

Sparta

Sparta Police: Rear End Collision After Two Mimosas Too Many

February 22, 2018

SPARTA, NJ – A car accident on Winona Parkway left two Sparta residents injured and another facing driving while intoxicated charges.  On February 18 around 7:49 p.m. Sparta Police Officer Steven Guido went to the scene of the accident along with Sgt. Schomp and Cpl. Antonello, police report.

Lisa Degraw, 55 had run into the back of Mark Iussig, 41 who was stopped at the red light ...

Sparta Police: Traffic Stop Yields Pile of Tickets and Active Warrants

SPARTA, NJ – A Newton woman, pulled over for a broken tail light on her black Kia ended up in custody.  On February 16 around 12:50 p.m. Sparta Police Officer Thomas Herd stopped Meagan Klein, 44, on Route 15, police report.

Herd also found the car’s registration was expired.  The car was not insured and Klein’s license was suspended.  The passenger, ...

First Hand Account: Shouts of Racial Slurs Bring Police to Sparta Theatre

SPARTA, NJ – Sparta police were called to the New Vision Sparta Theater on Sunday night because of a woman shouting slurs in a screening of Black Panther.

Former New Jersey Assembly candidate Michael Grace was in the theater when two people started yelling racial slurs including “look at these ‘n-word’” and “can you believe these ...

Upcoming Events

Sat, February 24, 7:00 PM

The Prudential Center, Newark

Sparta Education Foundation Night Out with the NJ ...

Giving Back Sports

Carousel_image_2f5911ae032b7193cdd2_girlscout_logo

Tue, February 27, 6:30 PM

Sparta United Methodist Church, Sparta

Girl Scout STEAM Program

Arts & Entertainment Education

Carousel_image_54f5549c693ec0512950_thedrowsychaperone_flyer

Fri, March 2, 7:00 PM

Wallkill Valley Regional High School, Hamburg

The Drowsy Chaperone

Arts & Entertainment

Carousel_image_563fe88c2c7424a0dce9_newton_rotary

Sat, March 3, 7:00 AM

First United Methodist Church, Newton

Newton Rotary Pancake Breakfast

Food & Drink

Carousel_image_54f5549c693ec0512950_thedrowsychaperone_flyer

Sat, March 3, 7:00 PM

Wallkill Valley Regional High School, Hamburg

The Drowsy Chaperone

Arts & Entertainment

Paterson's Poet Laureate

February 13, 2018

PATERSON, NJ- The City of Paterson has given birth to famous athletes, business leaders, actors, and now, a poet laureate.

Born and raised in Paterson, Talena Lachelle Queen told TAPinto Paterson that she has been writing since she was five-years old, and, as she grew older, realized that when it came to pursuing studies and a career in writing, she “didn’t have a choice.” ...

How to Talk with Kids About the Florida Shooting

February 15, 2018

The tragedy of the Florida school shooting is devastating, leaving 17 killed and 15 injured. Our children can easily identify with what occurred yesterday. It will be the topic of conversation today in schools everywhere. School administrators are doing all they can to provide support and guidance. The shootings affect children, teachers, and school personnel. The school shooting ...

Where Does YOUR School District Rank in Safety?

Family safety remains paramount when it comes to choosing a new home and community in New Jersey, so Team Nest Builder wants to help you know where top local school districts rank.

Niche.com, which specializes in all different types of consumer rankings, provided a list of the safest school districts in the United States and New Jersey. Below find a list of the 200 safest school ...

Top 5 Reasons to Hire a Real Estate Professional When Buying or Selling in NJ

Team Nest Builder knows that whether you are buying or selling a New Jersey home it can be quite the adventure, which is why you need an experienced real estate professional to guide you on the path to achieving your ultimate goal. But in this world of instant gratification and internet searches, many sellers think that they can ‘For Sale by Owner’ or ...

Does Marriage or Mortgage Come First?

According to the National Association of REALTORS most recent Profile of Home Buyers & Sellers, married couples once again dominated the first-time homebuyer statistics in 2017 at 57% of all buyers. Team Nest Builder knows it's no surprise that having two incomes to save for down payments and contribute to monthly housing costs makes buying a home more ...

Height during childhood associated with increased stroke risk in adulthood

Researchers in Denmark studied the health records of more than 300,000 people born between 1930 and 1989 and found that those who were shorter than average height between ages 7 and 13 had a greater risk of stroke as adults. The results of this study were published in the February 15, 2018 issue of the journal Stroke.

Summary: https://www.medicalnewstoday.com/articles/320922.php

Journal ...

Very Hot Tea Increases Cancer Risk

Researchers in China studying the consumption of “burning” hot tea, alcohol, and smoking habits of greater than 450,000 people ages 30 –79 for more than nine years found a five time greater risk of esophageal cancer in those who engaged in all three of the behaviors and a two time greater risk in those who either smoked or drank alcohol and consumed burning hot tea as compared ...

AtlantiCast

AtlantiCast: Episode 12

On this week’s episode of AtlantiCast, decade of excellence makes headlines, as Atlantic Health’s place on Fortune Magazine’s 100 Best Companies to Work For List leads off the newest episode of AtlantiCast. Also on this week’s show, check out the newest “hybrid” operating room at Morristown Medical Center and find out how Atlantic Health is helping local ...

AtlantiCast Medical Minute: Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center

On this episode of the AtlantiCast Medical Minute, we’ll take you inside the Atlantic Orthopedic Institute’s Scoliosis and Spinal Deformity Center, with the center’s director, Jason Lowenstein, MD.

Video Link: https://www.youtube.com/watch?v=1M7euCp86-c

Sussex County Board of Chosen Freeholders February 14 2018 Meeting Video

NEWTON, NJ - Sussex County Board of Chosen Freeholders February 14 2018 Meeting Video 

 

Sparta UMC Thrift Shop Holds Bag Sale

February 22, 2018

The Thrift Shop of the Sparta United Methodist Church, 71 Sparta Avenue, is holding a bag sale from Wednesday, MARCH 14TH through Saturday, MARCH 17TH.  Most items in the shop that can fit in a grocery bag can be purchased for $5 per bag. Shop Hours:  Wednesday and Saturday, 10 a.m. to 2 p.m.; Thursday and Friday, 1 p.m. to 4 p.m.  All proceeds support local, national, and global ...